News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
303,640 Results
Type
Article (15822)
Company Profile (288)
Press Release (287530)
Multimedia
Podcasts (51)
Webinars (9)
Section
Business (90544)
Career Advice (477)
Deals (15008)
Drug Delivery (41)
Drug Development (52438)
Employer Resources (73)
FDA (6325)
Job Trends (6310)
News (161146)
Policy (12142)
Tag
Academia (1164)
Academic (1)
Accelerated approval (3)
Adcomms (12)
Allergies (57)
Alliances (24911)
ALS (71)
Alzheimer's disease (923)
Antibody-drug conjugate (ADC) (102)
Approvals (6352)
Artificial intelligence (149)
Autoimmune disease (19)
Automation (7)
Bankruptcy (127)
Best Places to Work (5597)
BIOSECURE Act (8)
Biosimilars (45)
Biotechnology (236)
Bladder cancer (58)
Brain cancer (21)
Breast cancer (161)
Cancer (1564)
Cardiovascular disease (121)
Career advice (418)
Career pathing (8)
CAR-T (122)
Cell therapy (341)
Cervical cancer (9)
Clinical research (42696)
Collaboration (586)
Compensation (263)
Complete response letters (13)
COVID-19 (1134)
CRISPR (42)
C-suite (176)
Cystic fibrosis (78)
Data (1588)
Decentralized trials (1)
Denatured (14)
Depression (33)
Diabetes (151)
Diagnostics (1665)
Digital health (5)
Diversity (2)
Diversity, equity & inclusion (20)
Drug discovery (93)
Drug pricing (34)
Drug shortages (5)
Duchenne muscular dystrophy (90)
Earnings (33231)
Editorial (18)
Employer branding (7)
Employer resources (66)
Events (53924)
Executive appointments (497)
FDA (7095)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (530)
Gene editing (98)
Generative AI (11)
Gene therapy (261)
GLP-1 (404)
Government (1447)
Grass and pollen (2)
Guidances (32)
Healthcare (8371)
Huntington's disease (22)
IgA nephropathy (26)
Immunology and inflammation (95)
Indications (20)
Infectious disease (1201)
Inflammatory bowel disease (115)
Inflation Reduction Act (9)
Influenza (22)
Intellectual property (71)
Interviews (74)
IPO (8021)
IRA (14)
Job creations (1009)
Job search strategy (371)
Kidney cancer (7)
Labor market (11)
Layoffs (234)
Leadership (10)
Legal (2122)
Liver cancer (34)
Lung cancer (219)
Lymphoma (114)
Machine learning (4)
Management (25)
Manufacturing (156)
MASH (57)
Medical device (3512)
Medtech (3513)
Mergers & acquisitions (7347)
Metabolic disorders (415)
Multiple sclerosis (57)
NASH (13)
Neurodegenerative disease (72)
Neuropsychiatric disorders (26)
Neuroscience (1354)
NextGen: Class of 2025 (2796)
Non-profit (1674)
Now hiring (23)
Obesity (204)
Opinion (128)
Ovarian cancer (65)
Pain (46)
Pancreatic cancer (56)
Parkinson's disease (124)
Partnered (13)
Patents (137)
Patient recruitment (79)
Peanut (37)
People (29110)
Pharmaceutical (48)
Pharmacy benefit managers (5)
Phase I (14983)
Phase II (19769)
Phase III (12630)
Pipeline (882)
Policy (61)
Postmarket research (967)
Preclinical (6291)
Press Release (34)
Prostate cancer (67)
Psychedelics (36)
Radiopharmaceuticals (214)
Rare diseases (307)
Real estate (1730)
Recruiting (29)
Regulatory (9744)
Reports (18)
Research institute (1146)
Resumes & cover letters (46)
Rett syndrome (4)
RNA editing (5)
RSV (10)
Schizophrenia (61)
Series A (100)
Series B (64)
Service/supplier (1)
Sickle cell disease (43)
Special edition (12)
Spinal muscular atrophy (119)
Sponsored (17)
Startups (2107)
State (1)
Stomach cancer (4)
Supply chain (28)
Tariffs (12)
The Weekly (36)
Vaccines (235)
Venture capitalists (35)
Weight loss (119)
Women's health (16)
Worklife (9)
Date
Today (118)
Last 7 days (569)
Last 30 days (1638)
Last 365 days (21047)
2025 (6808)
2024 (22175)
2023 (24259)
2022 (29170)
2021 (30743)
2020 (27001)
2019 (20850)
2018 (15143)
2017 (15328)
2016 (13510)
2015 (16165)
2014 (11641)
2013 (8427)
2012 (8642)
2011 (8853)
2010 (8362)
Location
Africa (226)
Alabama (46)
Alaska (2)
Arizona (67)
Arkansas (6)
Asia (19710)
Australia (3212)
California (4065)
Canada (1281)
China (397)
Colorado (155)
Connecticut (181)
Delaware (107)
Europe (40478)
Florida (512)
Georgia (129)
Idaho (29)
Illinois (275)
India (14)
Indiana (110)
Iowa (2)
Japan (78)
Kansas (66)
Kentucky (6)
Louisiana (3)
Maine (14)
Maryland (546)
Massachusetts (3195)
Michigan (77)
Minnesota (173)
Mississippi (1)
Missouri (31)
Montana (21)
Nebraska (5)
Nevada (21)
New Hampshire (16)
New Jersey (1054)
New Mexico (14)
New York (1134)
North Carolina (610)
North Dakota (5)
Northern California (1785)
Ohio (120)
Oklahoma (10)
Oregon (21)
Pennsylvania (777)
Puerto Rico (6)
Rhode Island (22)
South America (299)
South Carolina (7)
Southern California (1547)
Tennessee (36)
Texas (500)
United States (14278)
Utah (65)
Virginia (88)
Washington D.C. (35)
Washington State (374)
West Virginia (1)
Wisconsin (19)
303,640 Results for "engage therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Job Trends
Employee Engagement, Workforce Sentiment Down in 2024
Global employee engagement fell two percentage points in 2024, according to Gallup, while
BioSpace
found that workforce sentiment decreased among biopharma professionals. Additionally, a recent
BioSpace
poll suggests engagement could continue to decline in 2025.
May 1, 2025
·
5 min read
·
Angela Gabriel
Press Releases
Xilio Therapeutics Announces Multiple Masked T Cell Engager Programs
February 12, 2025
·
9 min read
Press Releases
Context Therapeutics Presents Preclinical and Translational Data for CT-95, a Mesothelin Targeting T Cell Engager, at 2025 AACR Annual Meeting
April 30, 2025
·
4 min read
Press Releases
Neural Therapeutics Commences Trading, Provides Update on Growth Initiatives and Engages Investor Relations Consultants
March 17, 2025
·
8 min read
Press Releases
ME Therapeutics Announces It Has Engaged Lucosky Brookman LLP to Explore a Listing on the NASDAQ or NYSE
March 3, 2025
·
4 min read
Press Releases
Sunflower Therapeutics Engages PharmNXT Biotech LLP as Distributor for the Daisy Petal™ Perfusion Bioreactor System
February 26, 2025
·
3 min read
Press Releases
Cullinan Therapeutics to Initiate Study of CLN-978, a Bispecific CD19 T Cell Engager Administered Subcutaneously, in Patients with Sjögren’s Disease in the United States
April 30, 2025
·
8 min read
Press Releases
Clasp Therapeutics Doses First Patient in Phase 1 Clinical Trial With a First-in-Class T-Cell Engager Designed to Target Cancer Cells With Absolute Specificity
April 28, 2025
·
3 min read
Press Releases
Hemostemix Engages PatentVest to Strengthen its Global Patent Portfolio
April 23, 2025
·
1 min read
Press Releases
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Engage BTIG as Financial Advisor
February 3, 2025
·
7 min read
1 of 30,364
Next
